Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
International Journal of Clinical Oncology|July 4, 2013
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancersAyako Yanai, Yoshimasa Miyagawa, Keiko Murase, et al.
BMC Cancer|October 18, 2018
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxelKazuhiro Araki, Yoshinori Ito, Ippei Fukada, et al.
International Journal of Clinical Oncology|September 15, 2024
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancerAyumu Mitsuyoshi, Masayuki Nagahashi, Haruka Kanaoka, et al.
American Journal of Cancer Research|December 7, 2021
Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC)Yoshihisa Tokumaru, Masanori Oshi, Vijayashree Murthy, et al.
Breast Cancer (Tokyo, Japan)|May 18, 2019
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancersYukie Fujimoto, Takahiro Watanabe, Akira I Hida, et al.
Surgery|February 23, 2008
Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breastSatsuki Ueda, Yasuhiro Tamaki, Kenji Yano, et al.
Japanese Journal of Radiology|December 31, 2015
Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancerKazuhiro Kitajima, Kazuhito Fukushima, Yasuo Miyoshi, et al.
Cancer Research|October 4, 2018
HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNAWenwen Wu, Nana Rokutanda, Jun Takeuchi, et al.
Breast Cancer (Tokyo, Japan)|March 6, 2020
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin-but not with treatment of physician's choice-in the EMBRACE studyYasuo Miyoshi, Yuta Yoshimura, Kenichi Saito, et al.
Plos One|September 9, 2017
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancersArisa Nishimukai, Natsuko Inoue, Ayako Kira, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
International Journal of Clinical Oncology|July 4, 2013
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancersAyako Yanai, Yoshimasa Miyagawa, Keiko Murase, et al.
BMC Cancer|October 18, 2018
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxelKazuhiro Araki, Yoshinori Ito, Ippei Fukada, et al.
International Journal of Clinical Oncology|September 15, 2024
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancerAyumu Mitsuyoshi, Masayuki Nagahashi, Haruka Kanaoka, et al.
American Journal of Cancer Research|December 7, 2021
Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC)Yoshihisa Tokumaru, Masanori Oshi, Vijayashree Murthy, et al.
Breast Cancer (Tokyo, Japan)|May 18, 2019
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancersYukie Fujimoto, Takahiro Watanabe, Akira I Hida, et al.
Surgery|February 23, 2008
Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breastSatsuki Ueda, Yasuhiro Tamaki, Kenji Yano, et al.
Japanese Journal of Radiology|December 31, 2015
Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancerKazuhiro Kitajima, Kazuhito Fukushima, Yasuo Miyoshi, et al.
Cancer Research|October 4, 2018
HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNAWenwen Wu, Nana Rokutanda, Jun Takeuchi, et al.
Breast Cancer (Tokyo, Japan)|March 6, 2020
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin-but not with treatment of physician's choice-in the EMBRACE studyYasuo Miyoshi, Yuta Yoshimura, Kenichi Saito, et al.
Plos One|September 9, 2017
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancersArisa Nishimukai, Natsuko Inoue, Ayako Kira, et al.
Pageof 18